Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria

Steffen BorrmannTim PetoRobert W. SnowWin GutteridgeNicholas J. WhiteKenya Medical Research InstituteUniversitat HeidelbergJohn Radcliffe HospitalUniversity of OxfordMedicines for Malaria VentureMahidol University2018-07-122018-07-122008-11-01PLoS Medicine. Vol.5, No.11 (2008), 1546-155215491676154912772-s2.0-56749176780https://repository.li.mahidol.ac.th/handle/20.500.14594/19498Mahidol UniversityMedicineRevisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malariaReviewSCOPUS10.1371/journal.pmed.0050227